BridgeBio Pharma (BBIO) market cap

Market cap today
$14.96B

BridgeBio Pharma (BBIO) has a market cap of $14.96B. At the end of fiscal 2025 (December 31, 2025) its market cap was $14.65B. That is 186.9% higher than the $5.11B of fiscal 2024. Today's figure is 2.1% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$14.96B
Market cap, fiscal 2025
$14.65B
Change on fiscal 2024
+186.9%
Growth, 5 years
+11.8% a year
Highest on record
$14.65Bfiscal 2025
Lowest on record
$1.12Bfiscal 2022
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BridgeBio Pharma market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 11.8% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $14.65B in fiscal 2025 and the lowest $1.12B in fiscal 2022.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

BridgeBio Pharma market cap, year by year

BridgeBio Pharma (BBIO) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$14.96B—$76.80—
2025$14.65B 186.9% up$76.49191.53M
2024$5.11B 22.3% down$27.44186.08M
2023$6.57B 484.8% up$40.37162.79M
2022$1.12B 53.3% down$7.62147.47M
2021$2.41B 71.3% down$16.68144.36M
2020$8.39B—$71.11118.00M
2019——$35.05—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on BBIO

BridgeBio Pharma, figure by figure

BridgeBio Pharma (BBIO) overview: price, valuation and scorecardAll health care companies by market value

BridgeBio Pharma market cap: questions and answers

What is BridgeBio Pharma's market cap?

BridgeBio Pharma (BBIO) has a market cap of $14.96B. At the end of fiscal 2025 (December 31, 2025) its market cap was $14.65B. That is 186.9% higher than the $5.11B of fiscal 2024.

What is the growth rate of BridgeBio Pharma's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 11.8% a year.

What are the highest and lowest market cap figures on record for BridgeBio Pharma?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $14.65B in fiscal 2025 and the lowest $1.12B in fiscal 2022.

How is BridgeBio Pharma's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For BridgeBio Pharma it is on record here for 6 fiscal years, 2020 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BridgeBio Pharma (BBIO) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/BBIO/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.